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Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring 
patient experiences 
Abstract  
Background 
Expediting cancer diagnosis is widely perceived as one of the keys to improving patient outcomes. 
Evidence indicates that lymphoma diagnosis is often delayed, yet understanding of the issues 
influencing this is incomplete.  
Aim 
To H[SORUHSDWLHQWV¶SHUFHSWLRQVof disease-related factors affecting time to diagnosis of Hodgkin 
and non-Hodgkin lymphoma. 
Design and setting 
Qualitative UK study involving patients with indolent and aggressive lymphomas, and their 
relatives.  
Method 
Semi-structured interviews with 35 patients recruited from an established population-based cohort 
and 15 of their relatives. Interviews were audio-recorded and transcribed, and qualitative 
descriptive analysis undertaken. 
Results 
Accounts suggest that certain features of lymphoma can impact on patientV¶ and health care 
providers¶(HCPs) responses to disease onset. Three characteristics stand out: disease occurrence 
(rare), manifestation (varied), and investigative options (often inconclusive). Interviewees described 
how they (and some HCPs) lacked familiarity with lymphoma, seldom considering it a likely 
explanation for their symptoms. Symptoms reported were highly variable, often non-specific and 
said to be initially associated with various benign, self-limiting causes. Blood tests and other 
investigations, while frequently able to detect abnormalities, did not reliably indicate malignancy. 
Interviewees reported the potential for improvements among HCPs in information-gathering, 
communication of uncertainty, and re-presentation advice for non-resolving/progressive health 
changes. 
Conclusion 
Our evidence demonstrates the complex characteristics of lymphoma, perceived by patients as 
prolonging time to diagnosis, often despite significant effort by themselves, their relatives and 
HCPs to expedite this process. The findings also illustrate why simple solutions to delayed 
diagnosis are lacking in this area. 
Keywords  
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HOW THIS FITS IN  
Prior research identifies significant consequences of delayed cancer diagnosis, yet little is known 
about the factors affecting time to identification of lymphoma, despite these diseases being 
associated with late recognition. Our study explores lymphoma SDWLHQWV¶ DQGWKHLUUHODWLYHV¶ 
perceptions of disease related issues impacting on time to diagnosis; it is one of few to use 
qualitative methods and to explore patient experiences before and after first help-seeking. It 
highlights three important factors: the rare occurrence of lymphoma, its varied manifestation, and 
the investigative options available, which may be inconclusive. This evidence furthers 
understanding of when and why lymphoma diagnosis may be delayed; how delay can occur 
despite significant efforts on the part of patients, their relatives and health care providers; and 
how simple solutions to this issue are lacking.  
 
  
  
4 
 
Introduction  
Over a third of the 33,000 haematological malignancies diagnosed in the UK each year are 
lymphomas (1). These cancers comprise a heterogeneous group, with many distinct subtypes, 
which differ markedly in incidence, clinical pathways, and outcomes (2). For example, some 
subtypes are aggressive, progress rapidly, and are considered curable (such as diffuse large B-cell 
lymphoma and classical Hodgkin lymphoma); others are indolent, generally advance more 
gradually and are incurable (including follicular lymphoma and marginal zone lymphoma); and 
some may have both aggressive and indolent variants (e.g. mantle cell lymphoma). Definitive 
diagnosis generally requires examination of lymph node/extra-nodal and bone marrow tissue, 
along with a combination of specialist laboratory investigations (morphological, cytogenetic, 
immunocytochemistry and flow cytometry).  
Early stage diagnosis of cancer is important, as this is one means of improving SDWLHQWV¶survival 
(3) and quality of life (4). Despite this, the time leading to identification of lymphoma may be 
protracted and associated with avoidable delay (5,6). Unfortunately, although UK policy-based 
interventions (including referral guidance for GPs (7)), have resulted in improvements for several 
malignancies, these have had less impact for people with lymphoma (8). Patients with these 
cancers are still more likely to have multiple primary care appointments before hospital referral (9), 
and are less likely to be µIDVWWUDFNed¶ (two-week wait) by their GP (10). Furthermore, recent data 
also indicate that as many as two in five lymphoma diagnoses occur after emergency presentation, 
a route associated with late stage disease and poor survival (11).  
Research on time to cancer diagnosis has grown significantly in recent years. For lymphoma, 
studies have calculated the duration of time between specific events prior to diagnosis (e.g. onset 
of symptoms, first help-seeking, hospital referral); often drawing on survey data, either examining 
individual or combinations of subtypes, frequently alongside other cancers (5,8,12,13). Theoretical 
models now exist to facilitate time to diagnosis research, and ensure consistency in definitions, 
PHWKRGVDQGUHSRUWLQJ7KHµ0RGHORI3DWKZD\VWR 7UHDWPHQW¶037, is one example of this 
(14,15); it builds on earlier classification systems (16,17) and defines a linear series of intervals, 
events and processes, with several cross-cutting factors (Figure 1). These include; the µappraisal¶ 
interval (detection of bodily changes to decision to consult a health care provider ± HCP); the µhelp-
seeking¶ interval (decision to consult a HCP to first consultation); and the µdiagnostic¶ interval (first 
HCP consultation to diagnosis, including HCP appraisal, investigations, referrals and 
appointments).  
Factors affecting time to diagnosis remain relatively under-explored (18,19), however, and few 
studies have used qualitative methods to identify pertinent issues, including those addressing 
experiences after first help-seeking, either for lymphomas or other cancers (20±22). The aim of the 
current study was to improve understanding of experiences in the time leading to lymphoma 
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diagnosis, from the perspective of patients and family members, focusing on the impact of disease 
factors. To achieve this, we conducted a qualitative study, set within a large, ongoing patient cohort 
in the north of England (23), based on the intervals and events described in the MPT (14,15)  
Methods 
The study was carried out in accordance with the consolidated criteria for reporting qualitative 
studies (COREQ) (24) and guidance on standards for reporting qualitative research findings (25).  
Context  
The study is nested within the Haematological Malignancy Research Network (HMRN: 
www.hmrn.org), an ongoing population-based patient cohort established to generate evidence on 
haematological malignancies for research purposes and to inform clinical practice (2,26). 
Diagnoses (~2,400 annually, from a population of ~4 million in the Yorkshire & Humber region of 
the UK) are made by a single specialist laboratory and coded to the latest World Health 
Organization classification system (27). Core data are abstracted from medical records and 
patients are invited to complete a routine postal questionnaire soon after diagnosis, about their 
symptoms and help-seeking (including dates). 
Participants 
With appropriate ethical approval (REC 04/01205/69; REC 12/YH/0149), participants were 
identified from patients returning the routine postal questionnaire. Purposive sampling was used to 
ensure maximum variation in disease subtype, sex, age and time to diagnosis (Table 1). We 
approached 58 individuals, sending them information about the study and their potential 
involvement, and inviting them to participate; 35 expressed interest and were interviewed. Thirty 
patients had non-Hodgkin lymphoma (NHL; indolent and aggressive subtypes), and five Hodgkin 
lymphoma (HL); 18 were male; and median age at interview was 63 years (range 23-84). Patients 
were invited to ask a relative to take part in the interview if they wished, both to promote their own 
recall and so these family members could share their own perceptions; 15 agreed, all of whom 
invited their spouses/partners (Table 1). 
Data collection 
Potential participants were posted a study pack containing an introductory letter, information 
leaflet, response form, and prepaid return envelope. Those wishing to participate contacted the 
study team directly (via post or phone), and an interview was arranged. Two experienced 
qualitative researchers conducted the interviews (RH, DH), both of whom have significant track-
records in health services research, one of which was a former registered nurse (DH, Principle 
Investigator), with two decades of academic experience with haematology patients, their relatives 
and clinicians. Neither researcher was known to participants.  
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All patients were assured of data confidentiality and gave written consent to take part in the study. 
Interviews were conducted face-to-face, largely within patienWV¶KRPHV (two in the hospital setting), 
and within a year of diagnosis. Several early pilot interviews were conducted, followed by an 
intensive period of fieldwork between November 2015 and May 2016. Data collection was semi-
structured and guided by a schedule, which was informed by experience from within the research 
team and based on the appraisal, help-seeking and diagnostic intervals, as defined in :DOWHU¶V
MPT model (14,15). Issues included in the schedule are summarised in Table 2; precise questions 
were, however, adapted in situ to accommodate the full range of experiences and the manner in 
which patients chose to describe them. Interviews were digitally audio-recorded and, on average, 
completed in around 45 minutes.  
Data analysis 
Recordings were transcribed verbatim, field notes were used to confirm accuracy, and transcripts 
were checked and anonymised before import into the data management software, ATLAS-ti 
(Version 6.2.11). Our methodological orientation was qualitative description, a pragmatic approach 
producing minimally-theorized findings with practical applications (28,29). Analysis (RH and DH) 
was iterative, running alongside and informing data collection, which was discontinued once 
µVDWXUDWLRQ¶was achieved (30). After data familiarisation through reading/re-reading transcripts, 
several rounds of coding were undertaken, with constant comparison driving the refinement of 
codes. Memoing and mapping techniques (31) were used to explore patterns (i.e. similarities and 
differences between individuals) and relationships (between codes). The wider research team (ER 
and AS) had access to the data, analytical process and pathway maps which, along with codes 
and emerging themes, were regularly discussed and refined until consensus was reached.   
 
Results 
Based on the routine HMRN core postal questionnaire, in which patients document their symptoms 
and help-seeking activities, time from first symptom to diagnosis was found to vary markedly, the 
collective appraisal and help-seeking intervals having a median duration of 1 month (range 0.5-13), 
and the diagnostic interval 4 months (range 1-24). Accounts suggested that a combination of 
disease-related factors impacted on the behaviour of patientV¶, their relatives and HCPs in primary 
care (GPs and nurses). Three significant themes emerged; the occurrence of lymphoma (rare); its 
manifestation (varied); and investigation (often inconclusive) (Figure 2). These issues impacted on 
the assessment, interpretation and response to symptoms across the appraisal, help-seeking and 
diagnostic intervals, with recurrent activities (e.g. patient appraisal before and after first help-
seeking) preventing unilinear progression through each stage of the MPT before diagnosis. Each 
theme is described below with verbatim quotes. 
 
Occurrence 
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Interviewees perceived lymphoma as a relatively rare disease (in contrast to other cancers they 
were aware of, such as breast cancer), typically affecting older adults.  
An unfamiliar disease 
Few interviewees reported encountering anyone with lymphoma prior to diagnosis, and several 
had never heard of it before. Those who had, often described their knowledge as limited: µ,¶GKHDUG
of non-+RGJNLQ¶VO\PSKRPD,GLGQ¶WNQRZTXLWHZKDWLWPHDQW¶ (Patient 2: P2). Some said that at 
diagnosis, they had not initially known that lymphoma was a form of cancer. Awareness of Hodgkin 
lymphoma was somewhat greater, with several interviewees identifying this as life-threatening. 
However, prior knowledge of symptoms was consistently low. Some ± often younger ± patients 
reporting finding references to lymphoma when using the internet to facilitate symptom appraisal 
and the decision to seek help.  
Several interviewees also perceived HCPs as having limited exposure to, and familiarity with, 
lymphoma: µEHFDXVHLW¶VTXLWHUDUHDGRFWRU« PLJKWRQO\VHHRQHFDVHLQWKHLUH[LVWHQFH¶(P7). A 
few suggested HCPs were ill-equipped to recognise symptoms: µWKHGLDJQRVLVZDVGHILQLWHO\ODWH
QRGRXEWDERXWWKDW«WKHUH¶VQRWHQRXJKNQRZQDERXWWKHHDUO\V\PSWRPV¶(P24). This was said to 
prolong the diagnostic interval by holding up investigation and/or referral. Gaps in HCPs¶ 
knowledge seemed most problematic where symptoms were subtle and gradual in onset. Accounts 
suggest HCPs acted quickly and decisively (e.g. arranging emergency admission) when patients 
were acutely ill. 
An improbable disease 
Except for well-known common cancers associated with older age and gender, interviewees rarely 
perceived themselves as at risk of cancer as they appraised their symptoms: µI had this stupid 
QRWLRQWKDWLI,LI,DWHSURSHUO\DQGORRNHGDIWHUP\VHOI,¶GQHYHUJRGRZQZLWKDQ\WKLQJOLNHWKDW¶
(P4). They drew attention to prior health, healthy lifestyles, and lack of a family history: µFDQFHULVQ¶W
VRPHWKLQJWKDWUXQVLQRXUIDPLO\¶ (P31). Where internet searches returned references to 
lymphoma, this could therefore seem an unlikely explanation for symptoms: µ,ZHQWRQWKHLQWHUQHW
and read up. Well, when I started reading about cancer I just switched it off, because I thought, 
³1RQRWKDW¶VQRWULJKW´¶ (P5). Some interviewees suggested that perceptions of lymphoma as rare 
also inclined HCPs to judge it unlikely, and discount it as an explanation for symptoms during the 
diagnostic interval. One interviewee surmised age was also significant, with lymphoma dismissed 
due to their (relative) youth: µ,WKLQNWKH*3VNQHZWKHV\PSWRPVRIRIO\PSKRPD,MXVWGRQ¶WWKLQN
WKH\ZHUHZLOOLQJWRHUFRQVLGHUWKHPEHFDXVHRIP\DJH¶ (P6). 
 
Manifestation 
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Accounts revealed marked differences in symptom type and combinations, speed of onset, 
progression and intensity. Again, these characteristics affected the duration of the appraisal 
interval, the decision to seek help, and the length of the diagnostic interval. 
Highly variable  
Interviewees described a wide range of symptoms they had come to associate with onset of their 
lymphoma (Table 3). A few reported isolated changes, aside from which they felt well. In such 
instances help-seeking was often delayed, even where the symptom was widely associated with 
cancer (e.g. lumps, unexplained bleeding). The absence of pain seemed to provide reassurance: 
µIRUVRPHVWUDQJHUHDVRQ,¶GDOZD\VDVVXPHGWKHUHZRXOGEHSDLQ¶ (P2). Sometimes medical 
attention arose from help-seeking for other concerns. One interviewee described consulting their 
GP about a groin swelling: µVKHVDLGLW was a hernia, but she were more concerned about these 
[other] OXPSVZKLFK,FRXOGQ¶WXQGHUVWDQG«,ZD¶Q¶WKDYLQJDQ\SUREOHPVZLWKWKHP¶(P19). 
Meanwhile interviewees experiencing multiple symptoms were often slow to connect these or 
appraise them collectively. Some suggested HCPs were similarly late in doing this: µWKH«*3V«
never pieced it together. Whilst we [patient and relative] were looking at the symptoms individually, 
they [HCPs] ZHUHWRR¶ (P14).  
Something or nothing? 
Some interviewees, typically with seemingly aggressive disease, described rapid symptom 
development, with marked changes in their health. Severe and disruptive symptoms encouraged 
early help-seeking and ± unless the sole symptom was pain ± usually led to prompt investigation or 
referral to secondary care. However, many more described subtle symptoms, emerging insidiously 
or intermittently. These were often overlooked, or if appraised, judged unremarkable: µRQUHIOHFWLRQ
,KDGSRVVLEO\VRPHVZHDWLQJ«WKHVHWKLQJVDUHVRUWRIVRVORZDQGLPSHUFHSWLEOHWKDW\RXGRQ¶W
DOZD\V«WKLQNPXFKRILWDWWKHWLPH¶(P13). Non-specific feelings of being generally unwell were 
also often described (µYDJXHO\RII¶3µMXVWGLGQ¶WIHHOULJKW¶3¶) (Table 3). Interviewees perceived 
HCPs as under strain and felt a responsibility to determine if symptoms were important before 
seeking help: µ\RXNQRZWKH1+6KDVQ¶WJRWXQOLPLWHGUHVRXUFHVLQILQLWHUHVRXUFHVDQG,GRQ¶W
ZDQWWRZDVWHGRFWRUV¶WLPH¶ (P13). As part of the appraisal process, they often consulted friends 
and family about their symptoms and whether they should seek help from an HCP. Usually they 
were encouraged to see a doctor ± but not always: µ,VKRZHGWKHOXPSWRP\IULHQGVDQGWKH\VDLG
³<RX¶UHMXVWIUHDNLQJRXWLW¶VQRWKLQJZHFDQ¶WHYHQVHHWKHOXPS´¶ (P23). Intermittent symptoms 
were sometimes misconstrued as resolved, which could interrupt and extend the diagnostic interval 
(e.g. due to the cancellation of investigations).  
Plausible competing explanations 
Interviewees described how, as part of the appraisal process, they often initially identified 
alternative explanations for symptoms (Table 4); this was also common among HCPs in the 
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diagnostic interval. Expectations of age-related deterioration enabled patients to normalise many 
symptoms at this time, SHUFHLYLQJWKHPDVµFKDQJH¶, and not disease. Patients often attributed non-
specific symptoms and localised pain to lifestyle (e.g. hectic), life stage (e.g. menopause) or other 
conditions (e.g. hernia). They did not always report such changes to HCPs: µ,ZURQJO\DVVXPHGDW
the time, that it [night sweats] was associated with this [other] SUREOHP«:ith hindsight, perhaps, I 
VKRXOGKDYHPHQWLRQHGLW¶ (P30). HCPs too were recalled as proposing a range of explanations for 
symptoms in the diagnostic interval, including non-physical causes: µ[the GP] VDLG³:HOOZKDW¶V
probably happening is your body, you know, nRZWKDW\RXUPXP¶VJRQHLQWKH[nursing] home, your 
boG\LVVD\LQJµ3IIKWKDW¶VLW\RXNQRZMXVWUHOD[¶«DQGWKLVLVZK\\RX¶UHVOHHSLQJVRPXFK´¶ 
(P31).  
A few HCPs were described as attributing symptoms to psychological conditions including stress, 
anxiety and depression ± these examples mostly came from patients aged under 40 years. Many 
HCPs initially diagnosed other physical but non-malignant conditions: µWKHDVVXPSWLRQ[was] that it 
ZDVHULURQGHILFLHQF\DQGWKHYLWDPLQ%«WKH\ZHUHSHUKDSVDOLWWOHELWPRUHFRPSODFHQW
about the symptoms WKDQWKH\RXJKWWRKDYHEHHQ¶ (P11). These explanations often seemed 
plausible to patients (who had sometimes considered these explanations themselves), even in 
hindsight. HCPV¶UHDGLQHVV to consider more serious explanations, including malignancy, appears 
to have varied. Accounts suggest some considered cancer from the first help-seeking episode: 
µ+RQHVWWR*RGWKLVLVKRZLWKDSSHQHGKHWXUQHGDQGORRNHGDWPHDQGKHZHQW³cancer clinic for 
\RX´. HHNQHZVWUDLJKWDZD\¶ (P22). Others, however, seem to have done so only after treatment 
failure excluded benign explanations: µKHUHDOLVHGWKDWLWFDQ¶WEHWKDW[polymyalgia] because the 
VWHURLGVVKRXOGKDYHDOWHUHGLWDQGLWKD¶Q¶WGRQH¶ (P16). In many instances, patients re-appraised 
their symptoms after first help-seeking and re-presented to their GP ± sometimes on multiple 
occasions ± before HCPs undertook re-appraisal, initiated investigations, and/or discussed referral. 
Investigation 
In the diagnostic interval, interviewees described undergoing blood tests, various imaging/scans, 
and one or more biopsies, and reflected on the timing, costs and/or invasiveness of these, as well 
as the uncertainty of findings. 
Variation in access 
Accounts suggest considerable variation in when tests were undertaken, and at whose instigation. 
For example, some recalled having blood tests after first help-seeking, others only after several 
visits. One interviewee remarked: µWKHUHVHHPVWREHDUHVHUYDWLRQ«DERXWZKDWEORRGV\RXNQRZ
ZKDWEORRGVWRWDNHDQGZKDW¶VGRQHZLWKWKH[tests] ± ,VXSSRVHLW¶VPRQH\¶ (P24). A few described 
efforts to negotiate investigations. These were not always successful: µ[the Dr] VDLG³:HOO if we 
sent everybody for an x-UD\ZKRZDVFRPSODLQLQJRIDSDLQRUVRPHWKLQJWKHUH¶GEHTXHXHV
RXWVLGHPLOHVORQJ´¶ (P21). Access to MRI scans was portrayed as constrained, even where HCPs 
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viewed this as appropriate. A related issue was that investigations were typically conducted in 
sequence, with the results of one determining the need for another. Some interviewees viewed 
staggering tests as sensible: µWKHUHLVQRSRLQWSXWWLQJVRPHERG\WKURXJKVXUJHU\ [for a biopsy] that 
WKH\GRQ¶WQHHG¶ (P19). Others, however, were more critical: µ<RXZHQWIRUDELRSV\ODWHURQ«WR
find out what it was, what kind of cancer it was. But all these things, it drags on, and weeks go into 
PRQWKV«LW¶VDJRQLVLQJ¶ (Relative of P20).  
 
Results not always reliable or clear 
Participants commented on the reliability of available tests and the certainty with which they could 
detect disease. Some interviewees described getting decisive evidence of abnormality, suggestive 
of lymphoma or another serious condition. Many, however, reported receiving µQRUPDO¶or 
inconclusive results, in particular from blood tests and (to a lesser extent) imaging: µQRWKLQJ
VKRZHGXSLQP\EORRGQRDEQRUPDOLWLHV¶ (P18). Accounts suggest patients often interpreted 
normal UHVXOWVDVDQµDOOFOHDU¶ and a disincentive to further appraisal and help-seeking: µ,WKLQN
looking back, that that scan was very reassuring«DOOEORRGWHVWVZHUHJRRGWhat radiologist said 
HYHU\WKLQJORRNHGKHDOWK\«,IHOWTXLWHUHDVVXUHG¶ (P26). Others recalled inconclusive or 
ambiguous results, which could prove challenging for HCPs to interpret: µ[the GP] looked at the 
[blood results]«DQGKHVD\V³,FDQ¶WPDNHKead nor tail of this´¶ (P24). A few interviewees inferred 
gaps in HCPV¶ knowledge and understanding of how lymphoma might manifest in tests. They 
reported receiving a range of explanations for irregular bloods (infection, benign conditions, 
contamination) and enlarged lymph nodes (infection and/or injury). Where the significance of 
results was unclear, tests were typically repeated, but not always promptly: µ<RXZDLWHGVHYHQ
weeks for the [second] VFDQZKLFKLVWRRORQJ,WKDGGRXEOHGLIQRWPRUHLQVL]HE\WKDWWLPH¶ 
(Relative of P32).  
 
Discussion 
Summary 
This study aimed to improve understanding of disease-related factors affecting the time to 
diagnosis of lymphoma within the appraisal, help-seeking, and diagnostic intervals described in 
:DOWHU¶V0PT (14,15). It is novel in that findings are derived from patientV¶VHOI-reported 
experiences, and it examines activities before and after first help-seeking. Lymphoma occurrence 
was considered rare by interviewees, descriptions of its manifestation were varied, and patients 
often commented on the lack of specific investigations to clearly raise suspicion of cancer. These 
features resulted in a scenario whereby, with no (or very limited) knowledge, patients typically 
experienced the onset of subtle, non-specific symptoms or perceptions of ill-health, which during 
appraisal were often attributed to benign, mundane conditions, and/or non-physical, lifestyle and 
age-related factors. In the diagnostic interval, HCPs often faced an unfamiliar disease, with 
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symptoms similar to those of other common, non-malignant conditions, for which investigations did 
not reliably show abnormality or suggest malignancy; until symptoms progressed, the case for 
further tests/hospital referral was often unclear.  
Strengths and limitations 
Utilising qualitative methods DOORZHGXVWRHQJDJHZLWKWKHFRPSOH[LW\RISDWLHQWV¶self-reported, 
pre-diagnostic experiences, something previously identified as an important challenge (32). We 
included patients diagnosed with both indolent and aggressive lymphoma subtypes, and covered a 
broad range of age-groups, both sexes and varying pre-diagnostic time-intervals, including the 
period of time before and after first help-seeking. Our study sample and in-depth interview 
techniques yielded rich data that provide new insights into an important but under-researched area. 
To promote accurate recall, we largely interviewed patients within a year of diagnosis, encouraging 
reference to letters, calendars and diaries, and the involvement of family members.  
Accounts were not corroborated by review of medical records or HCP perspectives, as this was not 
the objective of the study. Compliant with ethical approvals, transcripts and findings were not 
returned to interviewees for verification. Transcripts were checked alongside interview recordings, 
however, and the study team was satisfied that the evidence generated largely reflected the 
experiences often reported by the patient population, both during clinical practice and at 
engagement events. We included patients who had previously returned a routine postal 
questionnaire, so did not capture the perspectives of those who either died soon after diagnosis, or 
who were not sent (or did not return) a questionnaire for other reasons (e.g. rapid health 
deterioration). Transferability' (i.e. consideration of findings in relation to their relevance for 
understanding similar issues and processes) is a key aspiration in qualitative research, rather than 
generalizability (33). Extrapolation should therefore take into account any study-specific contextual 
factors (e.g. different health-care systems; universal health-care coverage etc.), which may limit 
transferability (34). 
Comparison with existing literature 
Research into factors affecting time to lymphoma diagnosis specifically, and cancers more widely, 
has consistently identified patient tendencies to ascribe routine explanations to their symptoms 
(e.g. stress, normal ageing process/life phase), rather than recognising these as serious 
(20,22,35±37). Our results echo these findings; the broad range of symptoms described were often 
subtle, and did not always incorporate the commonRUµUHG-IODJ¶(38) characteristics listed on 
public-targeted lymphoma-specific websites (e.g. swollen lymph nodes, fatigue, weight loss or 
sweats (39)). Intermittent symptoms, interpreted by patients in our study as potentially resolved, 
were also considered reassuring among patients with other malignancies, such as pancreatic 
cancer (40); as were negative investigation results, by both patients and GPs (41±43). A recent 
systematic review of factors impacting on cancer diagnosis reported patient difficulties in assessing 
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the significance of vague, non-specific symptoms, and also perceptions that HCPs had not taken 
their concerns seriously, had not taken a thorough history, and had not asked relevant questions; 
patients were also anxious WKDWWKH\WKHPVHOYHVGLGQRWRYHUEXUGHQRUZDVWHGRFWRUV¶WLPH (44). 
Studies exploring factors after first help-seeking in primary care are perceived as limited, both with 
respect to lymphoma and other less familiar cancers (21,22). Available evidence suggests 
µSUDFWLWLRQHUGHOD\¶ is influenced by the nature of symptoms and how these are interpreted, as well 
as use of appropriate diagnostic testing and follow-up (42). Our study confirms that the relevance 
of these findings extends to lymphoma. Concurring with Walter¶V model (14,15), it also suggests 
SDWLHQWV¶LQWHUSUHWDWLRQVDQGDFWLRQVHJre-appraisal and re-presentation for ongoing symptoms) 
remain significant after first presentation, and that improved understanding of interactions between 
patients and HCPs is required.  
Implications for practice and research 
Although effective for some cancers (45,46), the characteristics of lymphoma may mean 
interventions such as education campaigns, aiming to facilitate appraisal, and encourage help-
seeking and specialist referral, are ineffective. This is due to the myriad of symptoms that may be 
experienced, which vary with the site of disease origin and spread (nodal/extra-nodal; 
organs/locations in the body). The vague symptoms noted as a consequence of ineffective 
lymphatic and bone marrow functioning (e.g. non-specific/multiple infections, anaemia-related 
fatigue), further compound this obstacle; as do differences in the severity, resulting dysfunction and 
pace of symptom progression, which are contingent on the lymphoma variant. For relatively rare 
conditions such as lymphoma, campaigns encouraging people to take note of changes in their 
body that persist/worsen RUGLYHUJHIURPZKDWLVµQRUPDO¶IRUWKHP, may be a more effective 
approach to encouraging help-seeking. 
Most people consult a GP in the diagnostic interval, preceding cancer diagnosis, even if the 
malignancy is identified following emergency presentation (41,47,48). Consequently, for both 
insidious and acute manifestations, GPs are faced with the complex task of differentiating benign 
symptoms from those that may indicate cancer. These decisions are made more difficult because 
the only high-risk factors indicative of lymphoma are unexplained lymphadenopathy (if present) in 
people aged 60 years and over, and an increase in consultation frequency to a doubling from 
normal in the year before diagnosis (49,50). Furthermore, the signs and symptoms of lymphoma 
FLWHGLQ8.UHIHUUDOJXLGDQFHDLPLQJWRVXSSRUW*3V¶FOLQLFDOHYDOXDWLRQDQGGHFLVLRQ-making (7), 
present only the most common symptoms, so are not ideal where clinical presentation deviates 
from this, a situation that the current study highlights as being common. The lack of investigations 
available to clearly identify or exclude lymphoma, as well as the propensity for normal inflammatory 
markers until late in the trajectory contributes a further complication (49,50). Unsurprisingly, a 
study with UK GPs reported the early detection of malignancy as particular burdensome, due to the 
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challenges in identifying potential cancer symptoms, managing cancer anxiety among patients and 
their families and making appropriate referrals (51).  
Certain aspects of the diagnostic interval are modifiable by HCPs, however, and may address 
some of the challenges raised by patients in our study. µ6DIHW\QHWWLQJ¶KDVEHHQVXJJHVWHGDVa 
means of managing diagnostic uncertainty, ensuring timely and appropriate follow-up, and avoiding 
emergency presentation, particularly where symptoms are non-specific or associated with µlow¶ 
cancer-risk, but not µno¶ cancer-risk (7,21,41,44,52). Strategies encouraged include effective and 
precise GP communication (to the patient/family) and documentation of issues such as uncertainty, 
potential signs of deterioration and/or complications, what to expect over time, and when, how and 
where to seek further help (e.g. for ongoing or worsening health-issues) and access test results 
(38,53). This approach would facilitate appropriate patient re-appraisal of symptoms and provide 
reassurance that repeated help-seeking was justified, and indeed may be required. In the 
diagnostic interval, it would provide HCPs with a useful summary of events, and highlight that 
uncertainty had been recognised. Furthermore, research into vague and/or non-site specific 
symptoms (e.g. weight loss) has led to recommendations for ways in which such manifestations 
VKRXOGEHPDQDJHGLQFOXGLQJWKHGHYHORSPHQWRIµYDJXHV\PSWRPV¶SDWKZD\V(7,54).  
Unfortunately, evidence from HCPs is absent for lymphoma, yet research with this group is crucial 
if the barriers and facilitators to timely diagnosis are to be wholly comprehended and relevant 
remedial strategies identified. 
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Figure 1 Model of Pathways to Treatment (14) 
 
HCP: Health Care Provider
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Figure 2 Summary of interviewee perceptions about disease-related factors and their impact on time to lymphoma diagnosis  
  
*HCP: Health Care Provider 
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Table 1 Participant characteristics (n=35) 
Diagnosis (Patient Identification) Patients (Relatives1) Females Males 
Age  
(years) 
Duration of appraisal and 
help-seeking intervals2, 3 
(months) 
Duration of diagnostic 
interval3,4 
(months) 
Median (range) Median (range) Median (range) 
Non-Hodgkin lymphoma 
       
Diffuse large B-cell 
(P2,4,8,9,20,21,24,27,29,31,32,35) 12 (7) 5 7 64 (48-81) 1 (0.5-13) 2.5 (1-14) 
Follicular  
(P1,3,6,10,12,13,18,22,26) 9 (2) 4 5 63 (39-84) 1 (0.5-12) 3 (1.5-15) 
Marginal zone 
(P5,16,25,28,30,33) 6 (1) 4 2 62 (57-76) 1 (0.5-10) 12 (3-25) 
Mantle cell  
(P11,15,34) 3 (3) 2 1 71 (70-75) 1 (1-6) 2 (2-10) 
 
      
Hodgkin lymphoma 
(P7,14,17,19,23) 5 (2) 2 3 36 (23-56) 0.5 (0.5-2) 5 (3-24) 
 
      
Total 35 (15) 17 18 63 (23-84) 1 (0.5-13) 4 (1-24) 
1All were spouses/partners of the interviewee with lymphoma; 2First symptom to first help-seeking; 3Estimate based on information provided by patients in the routine HMRN core 
questionnaire about symptoms and help-seeking; 4First help-seeking to diagnosis.  
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Table 2 Interview schedule 
Interviewees were asked to describe:  
1. The symptoms and health changes they experienced and how (in the appraisal, help-seeking 
and diagnostic intervals) these:  
o changed  
o were appraised and interpreted (by themselves, relatives and HCPs1) 
o were managed (by themselves, relatives and HCPs)  
2. Factors promoting and preventing timely appraisal, help-seeking and diagnosis 
3. Their knowledge and experience of lymphoma before diagnosis 
1Health Care provider
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Table 3 Pre-diagnostic symptoms considered due to lymphoma, as described by interviewees 
General feelings of ill health  
µFDQ¶WSXWILQJHURQLW¶µFRXOGQ¶WGRDQ\WKLQJ¶µJHQHUDOO\ORRNHGLOO¶µJHQHUDOO\XQZHOO¶µJURWW\¶µLPPXQLW\ZKDFNHG¶
µMXVWGLGQ¶WIHHOULJKW¶µMXVWIHOWURWWHQ¶µORXV\¶µVRPHWKLQJZURQJ¶µWKLQNLQJ³WKLVLVQ¶WULJKW´¶µXQGHUSDU¶µQRWIHH ling 
wHOO¶µQRWTXLWHULJKW¶, µRQHWKLQJDIWHUDQRWKHU¶µURXJK¶µVRPHWKLQJZDVQ¶WULJKW¶µWHUULEOH¶µXQGHUWKHZHDWKHU¶
µXQZHOO¶µYDJXHO\RII¶ 
 
Specific symptoms 
BleedingEUXLVLQJQRVHEOHHGVµSXPSLQJRXW¶YDJLQDOEOHHGLQJ 
Cognitive: confusion, loss of concentration, memory loss, mistakes at work  
Eating/drinking: appetite loss,  heartburn,  indigestion, nausea, reacting to alcohol/food, unable to eat, unable to 
keep food/water down, weight loss  
Faint/dizzy: blacking out, dizziness, lightheaded, near collapse, SDVVLQJRXWµZHLUGWXUQ¶ 
Gastro-intestinal: bloated, bulges/change in shape of stomach, constipation, diarrhoea/loose stool, feeling like 
something lodged in stomach, flatulence, jaundice, pancreatitis, SDVVLQJµZKLWHPDVV¶µpulsing¶ of stomach, stomach 
upset 
Genito-urinary: increased urination (µat night¶), loss of bladder control 
Lack of energy: fatigue, lethargy, tiredness, weakness. Characteristics - µDEQRUPDO¶µGHELOLWDWLQJ¶µGHVSHUDWH¶
µH[WUHPH¶µLPPHQVH¶µSURORQJHG¶µUHDOO\¶µYHU\¶Impact (general)µGHSOHWHG¶µIODWWHQHG¶µUHVHUYHVGLVDSSHDULQJ¶µQR
UHVHUYH¶µUXQQLQJRQHPSW\¶µsleeping more¶ µDORW¶µKRXUV¶µVKDWWHUHG¶µH[KDXVWLRQ¶µZRUQRXW¶µKRQHVWO\FRXOG
GURS¶Impact (on work/hobbies)µIOXFWXDWLQJFDSDFLW\IRUZRUN¶µXQDEOHWRGRDVPXFKDWJ\P¶µORVLQJILWQHVV¶
µGHWHULRUDWLQJILWQHVV¶ 
Mobility: difficulty walking, falls, tripping  
Mouth/taste: altered taste in mouth µPHWDOOLF¶µQDVW\¶µWDVWHEXGVFKDQJHG, mouth ulcers 
Infections: Characteristics ± fungal, recurrent, viral; Types - colds, cold sores, flu, flu-like symptoms, peri-anal 
abscess, pneumonia, sore throats, thrush, upper respiratory, urinary  
Pain: Characteristics ± µDVEDGDVWRRWKDFKH¶µEHQWGRXEOH¶ µFUDPS¶ µin agony¶, µQDJJLQJ¶µVFLDWLF-OLNH¶µVWDEELQJ¶
µterrific¶µ-RXWRI¶. Areas ± DEGRPHQDUPVEDFNFKHVWIHHWJURLQKHDGµSRXQGLQJ¶¶SXOVDWLQJ¶NQHHOHJV
lower back, ovary, shins, shoulder, stomach, thigh, rectal  
RespiratoryEUHDWKLQJGLIILFXOWLHVDWQLJKWEUHDWKOHVVQHVVFRXJKµGU\¶µEDG¶hoarse voice, post-nasal drip, vocal 
changes 
Neuro-sensory: aEQRUPDOVHQVDWLRQVEDFNµVRPHWKLQJUXEELQJ¶IHHWEXUQLQJµDVLI,¶GEHHQVFDOGHG¶ORVVRI
feeling in legs, numbness (legs), visual disturbances (µEODFNVSRWV
LQIURQWRIH\HV) 
Skin: change in colour of skin and whites of eyes (yellow, green/yellow), itchiness, itchy rash, not healing properly, 
µswollen spongy scalp¶  
Swellings/lumps: Areas (specific): groin, neck, armpit, abdomen/stomach, mouth, jawline, over collarbone, 
µJODQGV¶FDOIµRQZDLVW¶. Areas (general)OHJWKLJKIRRWµEDOORRQLQJ¶Changes: µstarted to hurt¶, µstarted to go a 
µEOXH\-SXUSOH¶FRORXU¶, µJURZLQJ« ELJJHUWKDQDJUDSHIUXLW¶ 
Temperature/sweats: high temperature, KRWIOXVKHVµUHDOO\FROG¶running a temperature, sweats (µday¶, µnight¶, 
µhorrendous¶, µhot¶) 
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Table 4 Appraisal and interpretation of symptoms by patients and their relatives 
Illnesses, comorbidities: allergy, back trouble, bad cold, cancer, crohns disease, cyst, dengue fever, 
depression, diverticulitis, effects of surgery, existing musculo-skeletal problems, grumbling appendix, 
haemorrhoids, hernia, hypochondria, irritable bowel, lupus, lymphoma, ME, picked something up, prostate 
cancer, slipped a disc, some strange fungal thing, stomach cancer, testicular cancer, tumour, parathyroid 
problems, ulcer, varicose veins, vertigo, vitamin D deficiency weakening muscles and bones 
Lifestyle, life-stage: age/ageing, bored, busy life, driving, family problems, fasting, heavy work, hectic, 
hormonal changes, injury (gym), lifting weights, µRQH-RII¶RYHUGRQHWKLQJVµPDQFKDQJH¶menopause, 
µmiddle-age spread¶ responsibilities and worries, retirement, rushing around, stress, too much cycling, 
work, 
Other: altitude, antibiotics, duvet too thick, season 
 
